News and Trends 19 Dec 2022
Sanofi and Innate Pharma expand natural killer cell deal
Sanofi and Innate Pharma SA have expanded their collaboration, with Sanofi licensing a natural killer (NK) cell engager program targeting B7H3…
Innate Pharma
- Latest Posts
News and Trends 29 Apr 2021
BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors
Bristol Myers Squibb’s recent phase III success provided the first late-stage confirmation for a novel immune checkpoint target in nearly…
In Depth 6 Jul 2020
How Immuno-Oncology Contributes to the Fight Against Covid-19
As the Covid-19 pandemic sweeps the world, cancer research is proving a valuable resource for developing new treatments for infectious…
More News! 17 Oct 2019
Sofinnova Partners Raises €333M for its Newest Life Sciences-Focused Fund
Sofinnova Partners, Europe’s largest VC focused on life sciences, has raised €333M to fund early-stage healthcare companies, bringing the total…
ADVERTISEMENT
News and Trends 17 Oct 2019
Innate Pharma Raises €62M IPO to Develop Antibody Drugs for Cancer
The French company Innate Pharma has raised a Nasdaq IPO of €62.1M ($68.8M) to fund the development of antibody immunotherapies…
News and Trends 22 Oct 2018
Innate’s Cancer Immunotherapy Combo Beats Standard Treatment Twofold
A combination cancer immunotherapy from French biotech Innate Pharma was twice as effective at treating recurrent squamous cell carcinoma as…
News and Trends 30 Jan 2018
Two Biotechs Team Up to Test their Cancer Antibody Combo in the Clinic
Innate Pharma and MedImmune will test the combination of Innate’s cancer antibody and the checkpoint inhibitor durvalumab in patients with solid…
Best in Biotech 12 Dec 2017
Grab the Tissues: Here are the 8 Biggest European Biotech Clinical Failures of 2017
As 2016 was a tough year for biotech, 2017 was under pressure to turn things around. Although there has been…
News and Trends 6 Jun 2017
French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug
Novo Nordisk has handed over its anti-cancer antibody to Innate Pharma in a new deal that could earn the diabetes…
News and Trends 6 Apr 2017
How is Biotech Transforming Pharma’s R&D Model?
Since the early 2000s, pharma has undergone a major reorganization. What roles do strategic alliances and acquisitions play in this…
ADVERTISEMENT
Infographics 13 Feb 2017
Infographic: What’s in Europe’s Immuno-oncology Pipeline?
While some might accuse the field of being over-hyped, immuno-oncology continues to attract attention and investment for its potential to cure cancer.…
News and Trends 6 Feb 2017
French Biotech’s Checkpoint Inhibitor Fails Phase II Leukemia Trial
Innate Pharma's checkpoint inhibitor candidate lirilumab missed its primary endpoint in a Phase II trial, which gave a hard blow…
News and Trends 6 Dec 2016
How is European Immuno-Oncology fighting Blood Cancer?
From leukemia to multiple myeloma, biotech is working hard to cure blood cancer. This year's edition of the American Society…
News and Trends 21 Apr 2016
These EU Biotechs presented groundbreaking results at World Biggest Cancer Meeting
The annual meeting of the American Association for Cancer Research (AACR) has just finished. From Europe, who made a splash…
News and Trends 7 Jan 2016
3 French Bioentrepreneurs are Awarded for Being Stubborn
Building a company is extremely difficult and obstination is sometimes needed to reach success. The organisation, France Biotech, has given…
News and Trends 24 Nov 2015
Money Money Money for Immuno-Oncology: BMS Joins up with a Top German VC
The World Leader in the Immuno-Oncology field has teamed up with a major German Investor to better identify breakthrough investment…
ADVERTISEMENT
News and Trends 14 Oct 2015
Innate Pharma receives $5M from its Monster-deal with BMS
This milestone payment from Bristol-Myers Squibb is part of the lirilumab licensing agreement, the monster immuno-oncology deal of €408M ($465M)…
News and Trends 28 May 2015
Biotechs outperformed in the top 40 European Tech Companies
EnterNext, the Euronext subsidiary dedicated to promoting and growing the market for SMEs (Small and Medium-size companies), announced the launch…